UK & Ireland – Life Sciences Labour Market Trends Report
Investment Fuels a New Era of UK & Ireland Life Sciences Hiring
The UK and Ireland’s Life Sciences sector is entering a new phase of growth, supported by increased investment, regulatory reform and accelerating scientific innovation. From biotechnology and pharmaceuticals to advanced therapeutics and AI-enabled drug discovery, employers are expanding recruitment to support the next generation of research and manufacturing.
This exclusive co-branded report from Vacancysoft and Cpl combines recruitment intelligence with expert market analysis to explore the trends shaping Life Sciences hiring across both markets, highlighting the sectors, skills and employers driving growth throughout 2026.
Key findings:
- UK Life Sciences hiring rebounds 13.3% as investment and regulatory reform drive growth.
- Ireland’s biotechnology vacancies surge 46.8%, leading scientific recruitment growth.
- UK Research & Development vacancies increase 68.4% amid record investment.
- PSC Biotech leads employer growth with Irish recruitment forecast to rise 118.2%.
Download a full report:
What’s inside:
Biotechnology leads the recovery
Biotechnology is emerging as the fastest-growing scientific discipline across both the UK and Ireland. In Ireland, vacancies are forecast to rise 46.8% as venture capital investment and multinational expansion accelerate recruitment, while UK biotechnology hiring is expected to increase 30.5%. As organisations invest in cell and gene therapy, engineering biology and AI-enabled drug discovery, demand continues to grow for specialists in bioprocess engineering, automation and computational biology.
Research investment accelerates hiring
Record investment in research infrastructure is driving strong demand for experienced scientific professionals. UK Research & Development vacancies are forecast to increase 68.4%, supported by more than £3 billion of investment and faster clinical trial approvals, while Ireland is strengthening its research capabilities through €460 million in new Research Ireland centres. Employers are increasingly competing for scientists capable of translating innovation into commercial and clinical success.
Specialist talent remains in high demand
As research programmes expand and manufacturing capacity grows, employers are sharpening their focus on specialist scientific talent. Organisations including PSC Biotech, Eurofins Scientific, IQVIA and Johnson & Johnson are increasing recruitment across medical affairs, regulatory affairs, quality assurance, validation engineering and clinical research. With competition for experienced professionals continuing to intensify, attracting specialist talent will remain central to the sector’s long-term growth.
